The toxicities included grade 3/4 cytokine release syndrome (CRS) occuring in 2 patients, as well as grade 3 confusional state, grade 2 infusion-related reaction, and a grade 3 nervous system disorder occuring in 1 patient each. In an interview with OncLive®, Wermke,...